Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Orum Therapeutics Inc. (475830)
Market Open
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
70,800.
00
+900
+1.2876%
₩
1.33T
Market Cap
-
P/E Ratio
-
Div Yield
47,748
Volume
-
Eps
₩
69,900
Previous Close
Watching
Watch
Add Transaction
Day Range
68,000
74,000
Year Range
22,050
146,600
Want to track
475830
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
Orum Therapeutics Inc. (475830) Statistics
Valuation metrics
Market Cap
1.33T
Enterprise value
1.23T
Trailing P/E (ttm)
-91.28
Forward P/E
-
PEG ratio
-0
Price/Sales (ttm)
89,439,658.22
Price/Book (mrq)
11.68
Enterprise Value/Revenue
83,553,886.6
Enterprise Value/EBITDA
-71.08
Overview
Shares outstanding
21.16M
Float
15.27M
Shares short
-
% Held by insiders
0.16%
% Held by institutions
0.02%
Average volume (10 days)
136.33K
Average volume (90 days)
185.51K
Price summary
52-Week low
22,050
52-Week high
146,600
Beta
-
50-Day moving average
50,480
200-Day moving average
83,745.93
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
-1,041,294.39%
Operating margin
-1,232,013.58%
Operational effectiveness
Return on assets
-0.05%
Return on equity
-0.22%
Income Statement
Revenue (ttm)
23.56M
Revenue per share (ttm)
0
Quarterly revenue growth (yoy)
-0.78%
Gross profit (ttm)
23.31M
EBITDA
-48.46B
Net income to common (ttm)
-41.97B
Diluted EPS (ttm)
-678.04
Quarterly earnings growth (yoy)
-0.77%
Balance Sheet
Total cash (mrq)
132.6B
Total cash per share (mrq)
12,151.68
Total debt (mrq)
25.5B
Total Debt/Equity (mrq)
0.22
Current ratio (mrq)
1.63%
Book value per share (mrq)
5,298.5
Cash Flow
Cash flow statement
-35.99B
Levered free cash flow (LFCF)
-19.89B